Contrave

DRUG3 trials

Sponsors

University of Nebraska, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Royal's Institute of Mental Health Research

Conditions

Breast CancerDietary InterventionObesityObesity/TherapyOverweight or ObesityWeight LossWeight Management

Phase 2

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study

CompletedNCT04499950

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBreast Cancer, Overweight or Obesity

Start: 2021-02-08End: 2024-01-10Updated: 2025-03-06

Phase 4

Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic

CompletedNCT03431831

University of NebraskaObesity

Start: 2017-07-01End: 2022-07-01Updated: 2024-08-29

Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity

RecruitingNCT06809166

The Royal's Institute of Mental Health ResearchDietary Intervention, Obesity, Obesity/Therapy +2

Start: 2024-07-04End: 2026-07-31Target: 40Updated: 2025-07-24

Related Papers

Pharmacotherapy as an adjunct to behavioral weight loss treatment in survivors of breast cancer.

Journal of Clinical Oncology2025-05-28

Secondary analysis of YFAS 2.0 symptom counts, impairment/distress, and food addiction severity in adults with overweight/obesity.

2021-01-038 citations